Accedi

Bibliografie tematiche / Inflammation Mediators / Articoli di riviste

Segui questo link per vedere altri tipi di pubblicazioni sul tema: Inflammation Mediators.

Articoli di riviste sul tema "Inflammation Mediators"

Autore: Grafiati

Pubblicato: 4 giugno 2021

Ultima modifica: 25 luglio 2025

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Inflammation Mediators".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.

1

Finsnes, Finn, Torstein Lyberg, Geir Christensen, and Ole H. Skjønsberg. "Effect of endothelin antagonism on the production of cytokines in eosinophilic airway inflammation." American Journal of Physiology-Lung Cellular and Molecular Physiology 280, no. 4 (2001): L659—L665. http://dx.doi.org/10.1152/ajplung.2001.280.4.l659.

Testo completo

Abstract (sommario):

Endothelin (ET)-1 has been launched as an important mediator in bronchial asthma, which is an eosinophilic airway inflammation. However, the interplay between ET-1 and other proinflammatory mediators during the development of airway inflammation has not been elucidated. We wanted to study 1) whether the production of ET-1 precedes the production of other proinflammatory mediators and 2) whether ET-1 stimulates the production of these mediators within the airways. These hypotheses were studied during the development of an eosinophilic airway inflammation in rats. The increase in ET-1 mRNA level

Gli stili APA, Harvard, Vancouver, ISO e altri

2

GREAVES, M. W. "Inflammation and mediators." British Journal of Dermatology 119, no. 4 (1988): 419–26. http://dx.doi.org/10.1111/j.1365-2133.1988.tb03245.x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

3

Sacca, R. "Mediators of inflammation." Current Opinion in Immunology 9, no. 6 (1997): 851–57. http://dx.doi.org/10.1016/s0952-7915(97)80189-6.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

4

Moore, Terry L., and Terry D. Weiss. "Mediators of inflammation." Seminars in Arthritis and Rheumatism 14, no. 4 (1985): 247–62. http://dx.doi.org/10.1016/0049-0172(85)90044-7.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

5

Lazarus, Stephen C. "Inflammation, Inflammatory Mediators, and Mediator Antagonists in Asthma." Journal of Clinical Pharmacology 38, no. 7 (1998): 577–82. http://dx.doi.org/10.1002/j.1552-4604.1998.tb04463.x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

6

Sudo, Maki, and Koichi Fujimoto. "Diffusive mediator feedbacks control the health-to-disease transition of skin inflammation." PLOS Computational Biology 20, no. 1 (2024): e1011693. http://dx.doi.org/10.1371/journal.pcbi.1011693.

Testo completo

Abstract (sommario):

The spatiotemporal dynamics of inflammation provide vital insights into the understanding of skin inflammation. Skin inflammation primarily depends on the regulatory feedback between pro- and anti-inflammatory mediators. Healthy skin exhibits fading erythema. In contrast, diseased skin exhibits expanding erythema with diverse patterns, which are clinically classified into five types: circular, annular, arcuate, gyrate, and polycyclic. Inflammatory diseases with expanding erythema are speculated to result from the overproduction of pro-inflammatory mediators. However, the mechanism by which fee

Gli stili APA, Harvard, Vancouver, ISO e altri

7

Alderton, Gemma. "Lipid mediators of inflammation." Science 371, no. 6526 (2021): 248.9–250. http://dx.doi.org/10.1126/science.371.6526.248-i.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

8

Robinson, Dwight R. "Lipid Mediators of Inflammation." Rheumatic Disease Clinics of North America 13, no. 2 (1987): 385–405. http://dx.doi.org/10.1016/s0889-857x(21)00854-1.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

9

Laurent, G. J. "Mediators of Pulmonary Inflammation." Thorax 47, no. 9 (1992): 764. http://dx.doi.org/10.1136/thx.47.9.764-a.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

10

Lasky, Laurence A. "Combinatorial mediators of inflammation?" Current Biology 3, no. 6 (1993): 366–68. http://dx.doi.org/10.1016/0960-9822(93)90203-z.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

11

du Bois, R. M. "Mediators of pulmonary inflammation." Immunology Today 13, no. 10 (1992): 424. http://dx.doi.org/10.1016/0167-5699(92)90100-l.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

12

Reilly, Christopher, Nicole Regna, and Abigail Peairs. "EGCG Inhibits Inflammation Independently of AMPK (87.10)." Journal of Immunology 184, no. 1_Supplement (2010): 87.10. http://dx.doi.org/10.4049/jimmunol.184.supp.87.10.

Testo completo

Abstract (sommario):

Abstract Epigallocatechin-3-gallate (EGCG), a bioactive component of green tea, has been reported to exert anti-inflammatory effects in immune cells. EGCG has been shown to activate the metabolic regulator, AMP-activated protein kinase (AMPK). Mesangial cells from MRL/lpr lupus-like mice are hyper-responsive to immune stimulation and overproduce nitric oxide (NO) and other inflammatory mediators when stimulated. In our current studies, we sought to determine if EGCG would inhibit inflammation in AMPK deficient mesangial cells. Cultured mesangial cells from MRL/lpr mice were treated with siRNA

Gli stili APA, Harvard, Vancouver, ISO e altri

13

Lu, Yan, Song Hong, Katherine Gotlinger, and Charles Serhan. "Lipid Mediator Informatics and Proteomics in Inflammation-Resolution." Scientific World JOURNAL 6 (2006): 589–614. http://dx.doi.org/10.1100/tsw.2006.118.

Testo completo

Abstract (sommario):

Lipid mediator informatics is an emerging area denoted to the identification of bioactive lipid mediators (LMs) and their biosynthetic profiles and pathways. LM informatics and proteomics applied to inflammation, systems tissues research provides a powerful means of uncovering key biomarkers for novel processes in health and disease. By incorporating them with system biology analysis, we review here our initial steps toward elucidating relationships among a range of bimolecular classes and provide an appreciation of their roles and activities in the pathophysiology of disease. LM informatics e

Gli stili APA, Harvard, Vancouver, ISO e altri

14

Ramon, Sesquile, Charles Serhan, and Richard Phipps. "Actions of novel inflammation-resolving lipid mediators on human B cells (84.9)." Journal of Immunology 184, no. 1_Supplement (2010): 84.9. http://dx.doi.org/10.4049/jimmunol.184.supp.84.9.

Testo completo

Abstract (sommario):

Abstract The resolution of inflammation is an active and dynamic process. Newly identified lipid mediators have been recognized as key players during the process of inflammation resolution. These lipid-derived molecules constitute three classes of compounds (lipoxins, resolvins and protectins), all derived from essential fatty acids. New data demonstrates that these lipid mediators regulate aspects of the immune response, including inhibition of neutrophil infiltration, reduction of T cell cytokine production and stimulation of macrophage phagocytic activity. However, their effects on B lympho

Gli stili APA, Harvard, Vancouver, ISO e altri

15

Eerden, Menno M. Van Der. "Mediators Of Inflammation In COPD." Pulmonary Medicine and Respiratory Research 5, no. 2 (2019): 1–10. http://dx.doi.org/10.24966/pmrr-0177/100026.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

16

Cooper, P. R., J. L. McLachlan, S. Simon, L. W. Graham, and A. J. Smith. "Mediators of Inflammation and Regeneration." Advances in Dental Research 23, no. 3 (2011): 290–95. http://dx.doi.org/10.1177/0022034511405389.

Testo completo

Abstract (sommario):

Characterization of the molecular response under caries lesions requires a robust and reliable transcript isolation system, and analysis of data indicated that collection of extracted teeth in either liquid nitrogen/RNA-stabilizing solution facilitated this. Subsequent transcriptional analysis indicated higher general activity in carious pulps, while characterization of inflammatory mediators, including cytokines and S100 proteins, highlighted increasing expression levels associated with both microbial front progression and elevated cellular immune response. Analysis of the pleiotropic hormone

Gli stili APA, Harvard, Vancouver, ISO e altri

17

Rankin, James A. "Biological Mediators of Acute Inflammation." AACN Clinical Issues: Advanced Practice in Acute and Critical Care 15, no. 1 (2004): 3–17. http://dx.doi.org/10.1097/00044067-200401000-00002.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

18

LUGER, T. "Mediators of immunity and inflammation." Journal of the European Academy of Dermatology and Venereology 11 (September 1998): S25—S26. http://dx.doi.org/10.1016/s0926-9959(98)94625-6.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

19

Rand, Royden. "Mediators of immunity and inflammation." Clinical Biochemistry 22, no. 3 (1989): 241–43. http://dx.doi.org/10.1016/s0009-9120(89)80083-9.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

20

Schlag, G., and H. Redl. "Mediators of Injury and Inflammation." World Journal of Surgery 20, no. 4 (1996): 406–10. http://dx.doi.org/10.1007/s002689900064.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

21

Agrawal, Anshu. "Vision for Mediators of Inflammation." Mediators of Inflammation 2020 (March 4, 2020): 1. http://dx.doi.org/10.1155/2020/9202849.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

22

Lai, Kar Neng, Sydney C. W. Tang, and Joseph C. K. Leung. "Mediators of Inflammation and Fibrosis." Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 27, no. 2_suppl (2007): 65–71. http://dx.doi.org/10.1177/089686080702702s12.

Testo completo

Abstract (sommario):

During peritoneal dialysis, peritoneal cells are repeatedly exposed to a non-physiologic hypertonic environment with high glucose content and low pH. Current sterile dialysis solutions cause inflammation in the submesothelial compact zone, leading to fibrosis, angiogenesis, and, eventually, ultrafiltration failure. Although the normal interstitium separates the peritoneal microvasculature from the dialysis fluid and makes transperitoneal transport less efficient, changes in the submesothelial compact zone can result in progressive increases in solute transfer and ultrafiltration diminution. Th

Gli stili APA, Harvard, Vancouver, ISO e altri

23

Abboud, Hanna E. "Cytokine mediators of renal inflammation." Current Opinion in Nephrology and Hypertension 3, no. 3 (1994): 329–33. http://dx.doi.org/10.1097/00041552-199405000-00015.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

24

Schirripa, Maria Laura, Maria Pia Scarpelli, and Cristian Palmiere. "Mediators of Inflammation in Asthma." American Journal of Forensic Medicine and Pathology 38, no. 2 (2017): 153–58. http://dx.doi.org/10.1097/paf.0000000000000306.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

25

Steinhubl, Steven R. "Platelets as Mediators of Inflammation." Hematology/Oncology Clinics of North America 21, no. 1 (2007): 115–21. http://dx.doi.org/10.1016/j.hoc.2006.11.015.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

26

Hoch, Matti, Jannik Rauthe, Konstantin Cesnulevicius, et al. "Cell-Type-Specific Gene Regulatory Networks of Pro-Inflammatory and Pro-Resolving Lipid Mediator Biosynthesis in the Immune System." International Journal of Molecular Sciences 24, no. 5 (2023): 4342. http://dx.doi.org/10.3390/ijms24054342.

Testo completo

Abstract (sommario):

Lipid mediators are important regulators in inflammatory responses, and their biosynthetic pathways are targeted by commonly used anti-inflammatory drugs. Switching from pro-inflammatory lipid mediators (PIMs) to specialized pro-resolving (SPMs) is a critical step toward acute inflammation resolution and preventing chronic inflammation. Although the biosynthetic pathways and enzymes for PIMs and SPMs have now been largely identified, the actual transcriptional profiles underlying the immune cell type-specific transcriptional profiles of these mediators are still unknown. Using the Atlas of Inf

Gli stili APA, Harvard, Vancouver, ISO e altri

27

Ishihara, Tomoaki, Mio Yoshida, and Makoto Arita. "Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis." International Immunology 31, no. 9 (2019): 559–67. http://dx.doi.org/10.1093/intimm/dxz001.

Testo completo

Abstract (sommario):

AbstractOmega-3 polyunsaturated fatty acids (PUFAs), including eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid, display a wide range of beneficial effects in humans and animals. Many of the biological functions of PUFAs are mediated via bioactive metabolites produced by fatty acid oxygenases such as cyclooxygenases, lipoxygenases and cytochrome P450 monooxygenases. Liquid chromatography–tandem mass spectrometry-based mediator lipidomics revealed a series of novel bioactive lipid mediators derived from omega-3 PUFAs. Here, we describe recent advances on omega-3 PUFA-derive

Gli stili APA, Harvard, Vancouver, ISO e altri

28

Harold Adrian, Liemena, Budi Satrijo, Djanggan Sargowo, and Indra Prasetya. "The Role of Colchicine in Acute Coronary Syndrome." Heart Science Journal 1, no. 4 (2020): 4–8. http://dx.doi.org/10.21776/ub.hsj.2020.001.04.02.

Testo completo

Abstract (sommario):

Background: Despite the advances of current optimal treatment of atherosclerotic disease, the incidence of events after acute coronary syndrome (ACS) remains high. Colchicine, with its well-established pleiotropic anti-inflam- matory effects, may inhibit NLRP3 inflammasome, a key mediator in atherosclerosis-associated inflammation (AAI) thus reducing systemic inflammation. NRLP3 inflammasome activation inside leukocytes (mainly monocytes and neutrophils) is precipitated by cholesterol crystals that are present in all atherosclerosis stages. 􏰟􏰋􏰡􏰈􏰇􏱎􏰋􏰇􏰆􏰂 􏰍􏰀􏰂􏰅􏰩􏰍􏰂􏰅􏰃􏰆 􏰃􏰜 􏰢􏰎􏰃􏰐􏰅􏰆􏰜􏰏􏰍􏰝􏰝􏰍􏰂􏰃􏰎􏰁 􏰀􏰁􏰂􏰃􏰄􏰅􏰆􏰇􏰈 􏰈

Gli stili APA, Harvard, Vancouver, ISO e altri

29

Bannenberg, Gerhard, Makoto Arita, and Charles N. Serhan. "Endogenous Receptor Agonists: Resolving Inflammation." Scientific World JOURNAL 7 (2007): 1440–62. http://dx.doi.org/10.1100/tsw.2007.188.

Testo completo

Abstract (sommario):

Controlled resolution or the physiologic resolution of a well-orchestrated inflammatory response at the tissue level is essential to return to homeostasis. A comprehensive understanding of the cellular and molecular events that control the termination of acute inflammation is needed in molecular terms given the widely held view that aberrant inflammation underlies many common diseases. This review focuses on recent advances in the understanding of the role of arachidonic acid and ω-3 polyunsaturated fatty acids (PUFA)–derived lipid mediators in regulating the resolution of inflammation. Using

Gli stili APA, Harvard, Vancouver, ISO e altri

30

Lam, Derek, Devon Harris, and Zhenyu Qin. "Inflammatory Mediator Profiling Reveals Immune Properties of Chemotactic Gradients and Macrophage Mediator Production Inhibition during Thioglycollate Elicited Peritoneal Inflammation." Mediators of Inflammation 2013 (2013): 1–9. http://dx.doi.org/10.1155/2013/931562.

Testo completo

Abstract (sommario):

Understanding of spatiotemporal profiling of inflammatory mediators and their associations with MΦ accumulation is crucial to elucidate the complex immune properties. Here, we used murine thioglycollate elicited peritonitis to determine concentrations of 23 inflammatory mediators in peritoneal exudates and plasma before (day 0) and after (days 1 and 3) thioglycollate administration to peritoneal cavities; these mediators included TNF-α, FGF-9, IFN-γ, IP-10, RANTES, IL-1α, IL-6, IL-7, IL-10, IL-11, IL-12p70, IL-17A, lymphotactin, OSM, KC/GRO, SCF, MIP-1β, MIP-2, TIMP-1, VEGF-A, MCP-1, MCP-3, an

Gli stili APA, Harvard, Vancouver, ISO e altri

31

Shavazi, Nurali Mamedovich Tagayeva Aziza Odiljonovna. "SARS IN NEONATOLOGY." Yosh olimlar 1, no. 8 (2023): 91–93. https://doi.org/10.5281/zenodo.8050697.

Testo completo

Abstract (sommario):

SARS is the most common pathology in both children and adults, especially in the winter period of diseases. Inflammation of the mucosa of the upper and lower respiratory tract is accompanied by hypersecretion of viscous mucus, edema of the mucous membrane of the respiratory tract, impaired mucociliary transport and bronchial obstruction. Inflammation of the mucous membrane occurs with the participation of humoral and cellular mediators of inflammation, the main role in this case belongs to the cellular mediator - eicosanoids.

Gli stili APA, Harvard, Vancouver, ISO e altri

32

Avenatti, R. C. "The intersection of inflammation, insulin resistance and ageing: implications for the study of molecular signalling pathways in horses." Comparative Exercise Physiology 8, no. 3-4 (2012): 153–71. http://dx.doi.org/10.3920/cep12018.

Testo completo

Abstract (sommario):

Inflammation-associated insulin resistance contributes to chronic disease in humans and other long-lived species, such as horses. Insulin resistance arises due to an imbalance among molecular signalling mediators in response to pro-inflammatory cytokines in the aged and obese. The mammalian heat shock protein response has received much attention as an avenue for attenuating inflammatory mediator signalling and for contributing to preservation and restoration of insulin signalling in metabolically important tissues. Data on heat shock proteins and inflammatory signalling mediators in untrained

Gli stili APA, Harvard, Vancouver, ISO e altri

33

Kharbanda, Rajat, and Tarun Bansal. "Adipokines: mediators of immunity and inflammation." International Journal of Research in Medical Sciences 8, no. 7 (2020): 2746. http://dx.doi.org/10.18203/2320-6012.ijrms20202929.

Testo completo

Abstract (sommario):

White adipose tissue has emerged as a highly dynamic organ that releases a plethora of immune and inflammatory mediators that are involved in obesity, metabolic syndrome and immune mediated diseases. Adipokines have complex role in various physiological and pathological processes by exerting potent modulatory actions on target tissues In this Review, In this review, we explore the effects of different adipokines, focusing primarily on leptin, adiponectin, visfatin and resistin in causing immune-mediated and/or inflammatory diseases.

Gli stili APA, Harvard, Vancouver, ISO e altri

34

Herkel, Johannes, and Dirk Schmidt-Arras. "Mediators of liver inflammation and carcinogenesis." Seminars in Immunopathology 43, no. 4 (2021): 477–79. http://dx.doi.org/10.1007/s00281-021-00880-x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

35

Flower, R. J. "Inflammation: The mediators of steroid action." Nature 320, no. 6057 (1986): 20. http://dx.doi.org/10.1038/320020a0.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

36

Jose, P. J. "Complement-derived peptide mediators of inflammation." British Medical Bulletin 43, no. 2 (1987): 336–49. http://dx.doi.org/10.1093/oxfordjournals.bmb.a072186.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

37

Lerner, Ulf H., and Goran Sundquist. "Mediators of inflammation-induced bone resorption." Dental Traumatology 7, no. 4 (1991): 186. http://dx.doi.org/10.1111/j.1600-9657.1991.tb00206.x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

38

Wallace, John L., Angela Ianaro, Kyle L. Flannigan, and Giuseppe Cirino. "Gaseous mediators in resolution of inflammation." Seminars in Immunology 27, no. 3 (2015): 227–33. http://dx.doi.org/10.1016/j.smim.2015.05.004.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

39

LUGER, T. "C057 Mediators of immunity and inflammation." Journal of the European Academy of Dermatology and Venereology 9 (September 1997): S70—S71. http://dx.doi.org/10.1016/s0926-9959(97)89132-5.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

40

Leid, R. Wes, and Kathleen A. Potter. "Inflammation and Mediators of Lung Injury." Veterinary Clinics of North America: Food Animal Practice 1, no. 2 (1985): 377–400. http://dx.doi.org/10.1016/s0749-0720(15)31332-3.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

41

FORD-HUTCHINSON, A. W., and ANITA RACKMAN. "Leukotrienes as mediators of skin inflammation." British Journal of Dermatology 109 (July 29, 2006): 26–29. http://dx.doi.org/10.1111/j.1365-2133.1983.tb06814.x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

42

BATSFORD, STEPHEN R. "Cationic antigens as mediators of inflammation." APMIS 99, no. 1-6 (1991): 1–9. http://dx.doi.org/10.1111/j.1699-0463.1991.tb05110.x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

43

Spiropoulos, Kostas, Nikolaos Siafakas, Marc Miravitlles, Francesco Blasi, and Kiriakos Karkoulias. "Mediators of Inflammation in Pulmonary Diseases." Mediators of Inflammation 2015 (2015): 1–2. http://dx.doi.org/10.1155/2015/739219.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

44

Bacon, Kevin B., and Thomas J. Schall. "Chemokines as Mediators of Allergic Inflammation." International Archives of Allergy and Immunology 109, no. 2 (1996): 97–109. http://dx.doi.org/10.1159/000237207.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

45

Scott, Dugald T., Francis Y. Lam, and William R. Ferrell. "Acute joint inflammation—Mechanisms and mediators." General Pharmacology: The Vascular System 25, no. 7 (1994): 1285–96. http://dx.doi.org/10.1016/0306-3623(94)90151-1.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

46

Lowry, Stephen F. "Cytokine Mediators of Immunity and Inflammation." Archives of Surgery 128, no. 11 (1993): 1235. http://dx.doi.org/10.1001/archsurg.1993.01420230063010.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

47

Shi, Xuan-Zheng, John H. Winston, and Sushil K. Sarna. "Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis." American Journal of Physiology-Gastrointestinal and Liver Physiology 300, no. 1 (2011): G41—G51. http://dx.doi.org/10.1152/ajpgi.00358.2010.

Testo completo

Abstract (sommario):

Crohn's disease and ulcerative colitis are clinically, immunologically, and morphologically distinct forms of inflammatory bowel disease (IBD). However, smooth muscle function is impaired similarly in both diseases, resulting in diarrhea. We tested the hypothesis that differential cellular, genetic, and immunological mechanisms mediate smooth muscle dysfunction in two animal models believed to represent the two diseases. We used the rat models of trinitrobenzene sulfonic acid (TNBS)- and dextran sodium sulfate (DSS)-induced colonic inflammations, which closely mimic the clinical and morphologi

Gli stili APA, Harvard, Vancouver, ISO e altri

48

Wallace, J. L. "Lipid mediators of inflammation in gastric ulcer." American Journal of Physiology-Gastrointestinal and Liver Physiology 258, no. 1 (1990): G1—G11. http://dx.doi.org/10.1152/ajpgi.1990.258.1.g1.

Testo completo

Abstract (sommario):

The interest in lipid mediators of inflammation as potential contributors to the pathogenesis of gastric ulcer has increased markedly over the past 20 yr. Although a great deal is known about the actions of mediators such as leukotrienes, thromboxane, and platelet-activating factor in experimental models of ulceration, evidence supporting a role for these mediators in human gastric ulcer is sorely lacking. This review attempts to answer a number of questions regarding the contribution of these mediators to the pathogenesis of gastric ulceration and the possible use of specific inhibitors, anta

Gli stili APA, Harvard, Vancouver, ISO e altri

49

Gushchin, Igor S. "Interactions of mast cells and eosinophils in allergic response." Russian Journal of Allergy 17, no. 2 (2020): 5–17. http://dx.doi.org/10.36691/rja1363.

Testo completo

Abstract (sommario):

Mast cells (MCs) and eosinophils (EOs) appeared hundreds of millions of years ago during the evolutionary process and continue to be retained by all vertebrate species. There is no convincing evidence of the absence of these cells in vertebrates under normal conditions. These cells are involved in the reactions of innate and adaptive immunity, in the control of tissue growth and tissue remodeling, activation of adipose tissue, affect reproductive functions and have a wide range of mediators involved in homeostasis. It is known that the interaction of these cells is involved in the initiation a

Gli stili APA, Harvard, Vancouver, ISO e altri

50

Knuplez, Eva, Eva Maria Sturm, and Gunther Marsche. "Emerging Role of Phospholipase-Derived Cleavage Products in Regulating Eosinophil Activity: Focus on Lysophospholipids, Polyunsaturated Fatty Acids and Eicosanoids." International Journal of Molecular Sciences 22, no. 9 (2021): 4356. http://dx.doi.org/10.3390/ijms22094356.

Testo completo

Abstract (sommario):

Eosinophils are important effector cells involved in allergic inflammation. When stimulated, eosinophils release a variety of mediators initiating, propagating, and maintaining local inflammation. Both, the activity and concentration of secreted and cytosolic phospholipases (PLAs) are increased in allergic inflammation, promoting the cleavage of phospholipids and thus the production of reactive lipid mediators. Eosinophils express high levels of secreted phospholipase A2 compared to other leukocytes, indicating their direct involvement in the production of lipid mediators during allergic infla

Gli stili APA, Harvard, Vancouver, ISO e altri

Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!